rabeprazole has been researched along with Infections, Respiratory in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of the present study was to evaluate 24-week maintenance of efficacy and safety of rabeprazole in children with endoscopically proven gastroesophageal reflux disease (GERD)." | 5.19 | Maintenance of efficacy and safety of rabeprazole in children with endoscopically proven GERD. ( Haddad, I; Hu, P; Kierkus, J; Leitz, GJ; Silber, S; Sloan, S; Tron, E; Ulmer, A, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haddad, I | 1 |
Kierkus, J | 1 |
Tron, E | 1 |
Ulmer, A | 1 |
Hu, P | 1 |
Silber, S | 1 |
Sloan, S | 1 |
Leitz, GJ | 1 |
1 trial available for rabeprazole and Infections, Respiratory
Article | Year |
---|---|
Maintenance of efficacy and safety of rabeprazole in children with endoscopically proven GERD.
Topics: Abdominal Pain; Child; Child, Preschool; Diarrhea; Double-Blind Method; Endoscopy, Gastrointestinal; | 2014 |